Pancreatic cancer is one of the most deadly
cancers with a poor prognosis. Although
microRNAs are involving in the
carcinogenesis and development of
pancreatic cancer, little information is known regarding the role of miR-663b in
pancreatic cancer. In this study, the expression of miR-663b in
pancreatic cancer cells was down-regulated by hypermethylation in its putative promoter region, and overexpression of miR-663b repressed cell proliferation, invasion and migration, and induced apoptosis in
pancreatic cancer cells. Bioinformatics analysis,
luciferase report assay and rescue experiments showed that
insulin-like growth factor 2 (IGF2) was a direct target of miR-663b. Results from clinical samples showed that the expression level of miR-663b correlated with the pathological grading, and the expression of miR-663b was down-regulated and was inversely correlated with IGF2 expression level in
pancreatic cancer tissues. More importantly, the
long non-coding RNA, HOX transcript
antisense RNA (HOTAIR), was up-regulated in both
pancreatic cancer cells and tissues, and HOTAIR suppressed the expression of miR-663b in
pancreatic cancer by
histone modification on
H3K4me3 and H3K27me3 on miR-663b promoter. Further in vivo studies demonstrated that the stable overexpression of miR-663b or knock-down of HOTAIR inhibited
tumor growth and was associated with IGF2 expression. In summary, our studies demonstrated that miR-663b is epigenetically repressed by HOTAIR and exerts its
tumor-suppressive function via targeting IGF2 in
pancreatic cancer.